SemOpenAlex |

SemOpenAlex

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065746813> ?p ?o ?g. }

Showing items 1 to 95 of 95 with 100 items per page.

W2065746813 endingPage "1551" @default.
W2065746813 startingPage "1547" @default.
W2065746813 abstract "TransfusionVolume 45, Issue 10 p. 1547-1551 Do we need to be more concerned about weak D antigens? George Garratty PhD, FRCPath, George Garratty PhD, FRCPath Scientific Director American Red Cross Blood Services Southern California Region 100 Red Cross Circle Pomona, CA 91768 e-mail: [email protected]Search for more papers by this author George Garratty PhD, FRCPath, George Garratty PhD, FRCPath Scientific Director American Red Cross Blood Services Southern California Region 100 Red Cross Circle Pomona, CA 91768 e-mail: [email protected]Search for more papers by this author First published: 19 September 2005 https://doi.org/10.1111/j.1537-2995.2005.00625.xCitations: 66Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Doescher A, Flegel WA, Petershofen EK, Bauerfeind U, Wagner FF. Weak D type 1.1 exemplifies another complexity in weak D genotyping. Transfusion 2005; 45: 1568-73. 2 Körmöczi GF, Förstemann E, Gabriel C, et al. Novel weak D types 31 and 32: Adsorption-elution–supported D antigen analysis and comparison to prevalent weak D types. Transfusion 2005; 45: 1574-80. 3 Denomme GA, Wagner FF, Fernandes BJ, Li W, Flegel WA. Partial D, weak D types, and novel RHD alleles among 33,864 multiethnic patients: implications for anti-D alloimmunization and prevention. Transfusion 2005; 45: 1554-60. 4 Yasuda H, Ohto H, Sakuma S, Ishikawa Y. Secondary anti-D immunization by Del red blood cells. Transfusion 2005; 45: 1581-4. 5 Flegel WA. Homing in on D antigen. Transfusion 2005; 45: 466-8. 6 Gassner C, Doescher A, Drnovsek TD, et al. Presence of RHD in serologically D–, C/E+ individuals: a European multicenter study. Transfusion 2005; 45: 527-38. 7 Lai M, Mavilla G, D’Onofrio G, Leone G. Detection of weak D with a fully automated solid-phase red cell adherence system. Transfusion 2005; 45: 689-93. 8 Chen Q, Flegel W. Random survey for RHD alleles among D+ European persons. Transfusion 2005; 45: 1183-91. 9 Stratton F. New Rh alleomorph. Nature 1946; 158: 25-8. 10 Agre PC, Davies DM, Issitt PD, et al. A proposal to standardize terminology for weak D antigen. Transfusion 1992; 32: 86-7. 11 Schmidt PJ, Morrison EC, Shohl J. The antigenicity of the Rho (Du) blood factor. Blood 1962; 20: 196-202. 12 Moore BPL. Does knowledge of Du status serve a useful purpose? Vox Sang 1984; 46(Suppl 1): 95-7. 13 Van Rhenen DJ. International round table conference on the definition of the Rh-negative blood donor. Vox Sang 1990; 58: 254-5. 14 Stroup M. Controversies in transfusion medicine. Du testing: Pro. Transfusion 1991; 21: 273-6. 15 Contreras M, Knight RC. Controversies in transfusion medicine: testing for Du: Con. Transfusion 1991; 21: 270-2. 16 Gibble JW, Shirey RS, Ness PM. The Du phenotype, serology, and clinical relevance. Crit Rev Clin Lab Sci 1984; 21: 229-53. 17 Tippett P, Lomas-Francis C, Wallace M. The Rh antigen D partial D antigens and associated low incidence antigens. Vox Sang 1996; 70: 123-31. 18 Issitt PD, Telen MJ. D, weak D (Du) and partial D: the molecular story unfolds. Transfusion 1996; 36: 97-100. 19 Domen RE. Policies and procedures related to weak D phenotype testing and Rh immune globulin administration. Arch Pathol Lab Med 2000; 124: 1118-21. 20 Jones J, Scott ML, Voak D. Monoclonal anti-D specificity and Rh D structure: criteria for selection of monoclonal anti-D reagents for routine typing of patients and donors. Transfus Med 1995; 5: 171-84. 21 Judd WJ, Moulds M, Schainser G. Reactivity of FDA-approved monoclonal anti-D reagents with partial D RBCs [abstract]. Transfusion 2002; 42(Suppl): 20S. 22 Westhoff CM. The Rh blood group system in press: a new face for the next decade. Transfusion 2004; 44: 1663-73. 23 Flegel WA, Wagner FF. RHD epitope density profiles of RHD variant red cells analyzed by flow cytometry. Transfus Clin Biol 1996; 6: 429-31. 24 Jones JW, Lloyd-Evans P, Kumpel BM. Quantitation of Rh D antigen sites on weak D and D variant red cells by flow cytometry. Vox Sang 1996; 71: 176-83. 25 Flegel WA, Curin-Serbec V, Delamaire M, et al. Section 1B: Rh flow cytometry. Coordinator's Report. Rhesus index and antigen density: an analysis of the reproducibility of flow cytometric determination. Transfus Clin Biol 2002; 9: 33-42. 26 Flegel WA, Khull SR, Wagner FF. Primary anti-D immunization by weak D type 2 RBCs. Transfusion 2000; 40: 428-34. 27 Beckers EA, Faas BH, Ligthart P, et al. Lower antigen site density and weak D immunogenicity cannot be explained by structural genomic abnormalities or regulatory defects of the RHD gene. Tranfusion 1997; 37: 616-23. 28 Wagner FF, Gassner C, Müller TH, et al. Three molecular structures cause Rhesus D category VI phenotypes with distinct immunohematologic features. Blood 1998; 91: 2157-68. 29 Wagner FF, Gassner C, Müller TH, et al. Molecular basis of weak D phenotypes. Blood 1999; 93: 385-93. 30 Wagner FF, Frohmajer A, Ladewig B, et al. Weak D alleles express distinct phenotypes. Blood 2000; 95: 2699-708. 31 Müller TH, Wagner FF, Trockenbacher A, et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion 2001; 41: 45-52. 32 Wagner Franz F, Frohmajer A, Flegel WA. RHD positive haplotypes in D negative Europeans. BMC Genet 2001; 2: 10-24. 33 Ansart-Pirenne H, Asso-Bonnet M, Le Pennec P, et al. RhD variants in Caucasians: consequences for checking clinically relevant alleles. Transfusion 2004; 44: 1282-6. 34 Mota M, Fonseca NL, Rodrigues A, Kutner JM, Castilho L. Anti-D alloimmunization by weak D type 1 red blood cells with a very low antigen density. Vox Sang 2005; 88: 130-5. 35 Wagner T, Körmöczi GF, Buchta C, et al. Anti-D immunization by DEL red blood cells. Transfusion 2005; 45: 520-6. 36 Chen JC, Lin TM, Chen YL, et al. RHD 1227A is an important genetic marker for RhDel individuals. Am J Clin Pathol 2004; 122: 193-8. 37 Leader KA, Kumpel BM, Poole GD, et al. Human monoclonal anti-D with reactivity against category DVI cells used in blood grouping and determination of the incidence of the category DVI phenotype in the Du population. Vox Sang 1990; 58: 106-11. 38 Beck ML, Hardman JT. Incidence of D category VI among Du donors in the USA [abstract]. Transfusion 1991; 31: 25S. 39 Beckers EA, Thijssen PM, Van Rhenen DJ. Prevalence and patterns of inheritance of partial RH D antigen category VI in a Caucasian population [abstract]. Transfusion 1993; 33: 74S. 40 Watt J. The incidence of category VI amongst weak Rh(D) positive Sydney blood donors [abstract]. Transfus Med 1993; 3(Suppl 1): 72. 41 Van Rhenen DJ, Thijssen PM, Overbeeke MA. Serological characteristics of partial D antigen category VI in 8 unrelated blood donors. Vox Sang 1994; 66: 133-6. 42 Standards for blood banks and transfusion services. 23rd ed. Bethesda: American Association of Blood Banks; 2004. 43 Avent ND. High variability of the RH locus in different ethnic backgrounds. Transfusion 2005; 45: 293-4. 44 Castilho L, Rios M, Rodrigues A, et al. High frequency of partial DIIIa and DAR alleles found in sickle cell disease patients suggests increased risk of alloimmunization to RhD. Transfus Med 2005; 15: 49-55. 45 Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham (NC): Montgomery Scientific Publications; 1998. 46 Williams M. Monoclonal reagents for Rhesus-D typing of Irish patients and donors: a review. Br J Biomed Sci 2000; 57: 142-9. 47 Anstee DJ. Goodbye to agglutination and all that? Transfusion 2005; 45: 652-3. Citing Literature Volume45, Issue10October 2005Pages 1547-1551 ReferencesRelatedInformation" @default.
W2065746813 created "2016-06-24" @default.
W2065746813 creator A5086688222 @default.
W2065746813 date "2005-09-19" @default.
W2065746813 modified "2023-10-15" @default.
W2065746813 title "Do we need to be more concerned about weak D antigens?" @default.
W2065746813 cites W146275532 @default.
W2065746813 cites W1486436563 @default.
W2065746813 cites W1507253825 @default.
W2065746813 cites W1556156479 @default.
W2065746813 cites W1580509081 @default.
W2065746813 cites W1852905216 @default.
W2065746813 cites W1967475332 @default.
W2065746813 cites W1976127615 @default.
W2065746813 cites W1980985575 @default.
W2065746813 cites W1998187763 @default.
W2065746813 cites W2014878214 @default.
W2065746813 cites W2015538414 @default.
W2065746813 cites W2035094450 @default.
W2065746813 cites W2046617452 @default.
W2065746813 cites W2047068597 @default.
W2065746813 cites W2049255964 @default.
W2065746813 cites W2050407013 @default.
W2065746813 cites W2057571660 @default.
W2065746813 cites W2067820929 @default.
W2065746813 cites W2072043535 @default.
W2065746813 cites W2084930351 @default.
W2065746813 cites W2090630523 @default.
W2065746813 cites W2091018848 @default.
W2065746813 cites W2091917999 @default.
W2065746813 cites W2092890609 @default.
W2065746813 cites W2093181579 @default.
W2065746813 cites W2101848691 @default.
W2065746813 cites W2107474109 @default.
W2065746813 cites W2116024968 @default.
W2065746813 cites W2123451910 @default.
W2065746813 cites W2124085252 @default.
W2065746813 cites W2127036604 @default.
W2065746813 cites W2128363881 @default.
W2065746813 cites W2135561167 @default.
W2065746813 cites W2144312212 @default.
W2065746813 cites W2153794913 @default.
W2065746813 cites W2169422649 @default.
W2065746813 cites W2170491715 @default.
W2065746813 cites W2739703910 @default.
W2065746813 cites W3023075903 @default.
W2065746813 doi "https://doi.org/10.1111/j.1537-2995.2005.00625.x" @default.
W2065746813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16181202" @default.
W2065746813 hasPublicationYear "2005" @default.
W2065746813 type Work @default.
W2065746813 sameAs 2065746813 @default.
W2065746813 citedByCount "80" @default.
W2065746813 countsByYear W20657468132012 @default.
W2065746813 countsByYear W20657468132013 @default.
W2065746813 countsByYear W20657468132014 @default.
W2065746813 countsByYear W20657468132015 @default.
W2065746813 countsByYear W20657468132016 @default.
W2065746813 countsByYear W20657468132017 @default.
W2065746813 countsByYear W20657468132019 @default.
W2065746813 countsByYear W20657468132020 @default.
W2065746813 countsByYear W20657468132021 @default.
W2065746813 countsByYear W20657468132022 @default.
W2065746813 countsByYear W20657468132023 @default.
W2065746813 crossrefType "journal-article" @default.
W2065746813 hasAuthorship W2065746813A5086688222 @default.
W2065746813 hasConcept C147483822 @default.
W2065746813 hasConcept C177713679 @default.
W2065746813 hasConcept C203014093 @default.
W2065746813 hasConcept C71924100 @default.
W2065746813 hasConceptScore W2065746813C147483822 @default.
W2065746813 hasConceptScore W2065746813C177713679 @default.
W2065746813 hasConceptScore W2065746813C203014093 @default.
W2065746813 hasConceptScore W2065746813C71924100 @default.
W2065746813 hasIssue "10" @default.
W2065746813 hasLocation W20657468131 @default.
W2065746813 hasLocation W20657468132 @default.
W2065746813 hasOpenAccess W2065746813 @default.
W2065746813 hasPrimaryLocation W20657468131 @default.
W2065746813 hasRelatedWork W1506200166 @default.
W2065746813 hasRelatedWork W1995515455 @default.
W2065746813 hasRelatedWork W2048182022 @default.
W2065746813 hasRelatedWork W2080531066 @default.
W2065746813 hasRelatedWork W2414745257 @default.
W2065746813 hasRelatedWork W2748952813 @default.
W2065746813 hasRelatedWork W2899084033 @default.
W2065746813 hasRelatedWork W3031052312 @default.
W2065746813 hasRelatedWork W3032375762 @default.
W2065746813 hasRelatedWork W3108674512 @default.
W2065746813 hasVolume "45" @default.
W2065746813 isParatext "false" @default.
W2065746813 isRetracted "false" @default.
W2065746813 magId "2065746813" @default.
W2065746813 workType "article" @default.